Clinical indication
Test selection starts with clinical findings, history and previous results.
Whole-genome sequencing of the fetus, with comparative parental analysis.
A comprehensive genomic approach to investigating genetic conditions when clinically indicated, in collaboration with the treating clinician and supported by genetic counselling.
Prenatal genomic testing can help investigate genetic conditions in selected pregnancies, particularly when fetal anomalies or other findings raise a specific clinical suspicion.
Test selection starts with clinical findings, history and previous results.
Comparing fetal and parental data helps interpret the origin of variants.
Counselling before and after testing, with a clear discussion of capabilities, limitations and possible outcomes.
Analysing the fetus alongside the mother and father helps distinguish inherited and possible de novo findings and assess potential inheritance patterns.
Genetic information
Genetic information
Clinical findings + WGS
Variant origin · inheritance pattern · relevance to the fetal phenotype
A variant’s absence from the parents does not by itself establish that it is pathogenic. Each finding requires clinical and laboratory evaluation.
WGS generates data from coding and non-coding regions of the genome. Analysis focuses on findings that may be relevant to the pregnancy’s clinical indication.
Single-nucleotide variants and small insertions or deletions in assessable regions.
Assessment of copy-number changes or structural variants where the relevant analysis has been validated.
Assessment of selected non-coding findings when sufficient evidence supports clinical relevance.
Testing is planned with the treating clinician and genetics specialists. Fetal sampling is performed by the responsible obstetrician when indicated.
Clinical findings, history and informed consent.
Fetal DNA and appropriate parental samples.
Quality assessment and comparative family analysis.
Explanation of findings and discussion of next steps.
DNA from amniotic fluid or chorionic villi, according to the clinical decision and laboratory requirements.
Appropriate samples from both biological parents, following laboratory instructions.
Results are always interpreted in relation to the fetal phenotype. Reporting policies and possible uncertainties are discussed before testing.
A finding that may contribute to a genetic diagnosis and counselling for the family.
A negative result does not exclude every genetic condition or every possible cause of the findings.
Some findings may remain uncertain; assessment and reporting follow clinical policy and consent. A variant of uncertain significance does not establish a diagnosis.
Prenatal genomics requires appropriate case selection, validated laboratory analysis and informed genetic counselling.
Joint ESHG and ISPD recommendations on diagnostic genomic sequencing in prenatal care, emphasising clinical indication, counselling and appropriate interpretation.
DOI: 10.1038/s41431-026-02217-4View source ↗A study in selected pregnancies with fetal anomalies examining the diagnostic use of WES and WGS. Its findings do not estimate performance across all pregnancies.
DOI: 10.1002/pd.6402View source ↗Your clinical team will help you understand which test addresses the specific question in your pregnancy.
No. Trio WGS here refers to diagnostic analysis of fetal DNA from amniotic fluid or chorionic villi when indicated. NIPT is a different screening test performed using maternal blood.
Prenatal diagnostic genomics is used after clinical assessment. Suitability depends on findings, family history and previous investigations.
No. Detection capabilities differ by finding type. The clinical team may recommend complementary or confirmatory tests depending on the indication and validated analysis.
It means that no diagnostic explanation was identified within the scope and limits of the analysis. It does not guarantee that all genetic or other conditions have been excluded.
The NeoScreen team can explain the test, sample collection and coordination with your clinician.